Arrowhead Pharmaceuticals ARWR
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 66.39 | 568 | 5.96 | 31 | 2.06 | 1,604 |
| 2025Q3 | 34.49 | 466 | -4.81 | -24 | -1.72 | 1,385 |
| 2025Q2 | 15.80 | 522 | -29.07 | -175 | -11.86 | 1,381 |
| 2025Q1 | 12.74 | 683 | 100.68 | 370 | 28.64 | 1,573 |
| 2024Q4 | 18.80 | 53 | -145.43 | -173 | -16.07 | 1,014 |
| 2024Q3 | 19.37 | 185 | -66.10 | -171 | -16.86 | 1,140 |
| 2024Q2 | 25.99 | 331 | -41.95 | -171 | -18.58 | 884 |
| 2024Q1 | 28.60 | 484 | -38.90 | -125 | -15.85 | 955 |
| 2023Q4 | 30.60 | 160 | -61.55 | -133 | -19.09 | 626 |
| 2023Q3 | 26.87 | 271 | -34.48 | -110 | -14.05 | 766 |
| 2023Q2 | 35.66 | 365 | -25.37 | -103 | -12.20 | 796 |
| 2023Q1 | 25.40 | 447 | 11.82 | 49 | 5.46 | 891 |
| 2022Q4 | 40.56 | 377 | -10.66 | -41 | -5.22 | 891 |
| 2022Q3 | 33.05 | 399 | -20.06 | -86 | -11.85 | 692 |
| 2022Q2 | 35.21 | 454 | -15.90 | -72 | -9.90 | 752 |
| 2022Q1 | 45.99 | 452 | 10.76 | 44 | 6.61 | 704 |
| 2021Q4 | 66.30 | 373 | -16.09 | -63 | -9.32 | 639 |
| 2021Q3 | 62.43 | 409 | -14.99 | -63 | -8.77 | 710 |
| 2021Q2 | 82.82 | 437 | -6.78 | -30 | -4.01 | 735 |
| 2021Q1 | 66.31 | 446 | -5.96 | -27 | -4.27 | 757 |